Latest Urinary Tract Infections (UTI) News
Overall treatment success occurred in 98.4% of patients receiving meropenem-vabobactam vs 94% for those receiving piperacillin-tazobactam.
A Charlson Comorbidity Index score of 2 or higher is an independent risk factor for urinary tract infections within 90 days following radical cystectomy for bladder cancer, study finds.
Nitrofurantoin, trimethoprim-sulfamethoxazole prescribed first trimester despite ACOG recs.
Confusion independently associated with receipt of antibiotics for UTI in nursing home residents.
Study shows test is sensitive and specific in infants younger than 60 days old.
No worse sexual or urinary function, but incidence of urethral stricture higher than swimmers/runners.
New analysis finds that female sex and non-dilating vesicoureteral reflux are independently associated with an increased risk of bladder and bowel dysfunction.
Symptom resolution at day 3 was met by 54% in the diclofenac group vs 80% in the norfloxacin group.
Almost one-fourth of retail poultry contains E. coli strains associated with urinary tract infections
Kidney transplant recipients who experience recurrent urinary tract infections are at increased risk of graft failure and death.
Vabomere, which combines meropenem and vaborbactam, demonstrated superior efficacy to piperacillin/tazobactam.
In a study of renal transplant patients who received ureteral stents, ciprofloxacin did not lower the incidence of UTI compared with SMX-TMP.
The researchers reaffirmed the 2011 UTI clinical practice guideline on infants and young children and reiterated the seven key action statements.
Meropenem-vaborbactam has the potential to be an important new drug in the treatment of patients with serious infections due to resistant organisms.
The researchers found no significant difference in the percent of women who had bacteriuria plus pyuria among those taking cranberry capsules or placebo.
Renal and Urology News Articles
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)